• Aucun résultat trouvé

“What is original in an original royal charter?” – Research Associate

N/A
N/A
Protected

Academic year: 2022

Partager "“What is original in an original royal charter?” – Research Associate"

Copied!
2
0
0

Texte intégral

(1)

* Full-time positions currently comprise 39 hours per week.

Cluster of Excellence "Understanding Written Artefacts: Material, Interaction and Transmission in Manuscript Cultures" invites applications for a

RESEARCH ASSOCIATE FOR THE PROJECT “What is orig- inal in an original royal charter? Re-evaluation and a new approach to writing and validation of western early medieval diplomas”

- SALARY LEVEL 13 TV-L -

The position in accordance with Section 28 subsection 3 of the Hamburg higher education act (Hamburgisches Hochschulgesetz, HmbHG) commences on 01.10.2019.

This is a fixed-term contract in accordance with Section 2 of the academic fixed-term labor con- tract act (Wissenschaftszeitvertragsgesetz, WissZeitVG). The term is fixed for a period of three years. The position calls for 75% of standard work hours per week.

Responsibilities:

Duties include academic services in the project named above. Research associates may also pur- sue independent research and further academic qualifications.

Specific Duties:

Research in the frame of the project “What is original in an original royal charter? Re-evaluation and a new approach to writing and validation of western early medieval diplomas”. The position includes the enrolment in the Cluster's graduate school, and requires participation in research colloquia, lecture series and workshops, as well as active engagement in the Cluster's research activities.

Requirements:

A university degree in a relevant field. Expertise in Diplomatics, Palaeography, and Medieval Latin is expected. Fluent English, written and spoken.

(2)

Universität Hamburg has been certified.

audit familiengerechte hochschule

The University aims to increase the number of women in research and teaching and explicitly encourages women to apply. Equally qualified female applicants will receive preference in ac- cordance with the Hamburg act on gender equality (Hamburgisches Gleichstellungsgesetz, HmbGleiG).

Qualified disabled candidates or applicants with equivalent status receive preference in the ap- plication process.

For further information, please contactProf. Dr. Philippe Depreux (philippe.depreux@uni-ham- burg.de) or consult our website at https://www.written-artefacts.uni-hamburg.de/en.html.

Applications (in English) should include a cover letter, a tabular curriculum vitae, and copies of degree certificate(s). Please send applications by 23 August 2019 to:

applications.csmc@uni-hamburg.de .

Please do not submit original documents as we are not able to return them. Any documents sub- mitted will be destroyed after the application process has concluded.

Références

Documents relatifs

In the first model, the existence or absence of a  chronic disease was included, and the results showed that participants with health problems had significantly lower levels of HL

Objective: We aimed to determine the effect of low concentration of Mycobacterium tuberculosis (MTB) in sputum samples reported by GeneXpert on discordant results

We examined the diagnostic yield of surgical biopsy and accuracy of Xpert MTB/RIF using pleural fluid and biopsy samples among patients with unexplained pleural effusion in

The work on which this article was based was commissioned and funded by the Arts Council and Health Service Executive (HSE) in Ireland and presented in the report titled Research

We undertook a retrospective cohort study of notified paediatric TB cases and household contacts in Dushanbe, Tajikistan from 2009 to 2013 to investigate trends in, and

The quantitative (i.e. results given as numbers and percentages) and qualitative analysis of important variables related to each CINDI step included: (i) specification of

To be included in the study, managerial staff had to be familiar with the issues of health care data management within the health-care facility and aware of the national

Conclusion: For successful outcomes, all DR-TB treatment regimens, including resistant drug(s), should be adjusted based on the DST profile, regardless of the type